Caribbean ECMO registry launches to track Life-Saving machine outcomes
NCT ID NCT07351435
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will collect information from 1,200 patients in the French West Indies and Guiana who received ECMO, a machine that helps the heart and lungs. Researchers aim to track survival rates and complications to better understand how ECMO works in this region. The study does not test a new drug or device, but gathers real-world data.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide valuable insights into ECMO use and outcomes in the Caribbean region, potentially improving care guidelines.
- What could go wrong
- This is an observational registry, not a treatment trial, so it won't directly test a new therapy. Data collection may be incomplete, limiting conclusions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,200 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2033
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All consecutive patients implanted with a VV-ECMO, VA-ECMO or VAV-ECMO device by the UHM HeartTeam
- Ages
-
Up to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All consecutive patients implanted with a veno-venous extracorporeal membrane oxygenation device or extracorporeal membrane oxygenation device by the HeartTeam from the University Hospital of Martinique (UHM) from January 2010 Exclusion Criteria: * Patients with incomplete data (primary endpoint and less than 80% secondary study outcomes)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute respiratory failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The heart rhythm threat hiding in heart attack wards
- Stick-On patch aims to catch dangerous heart decline sooner
- Hand position in CPR: does comfort compromise compression quality?
- Can two blood markers catch sepsis before it turns deadly?
- Short CPR practice sessions at work may sharpen hospital resuscitation skills
- Two cheap blood ratios put to the test as sepsis death predictors